This course offers an in-depth look at Lp(a)’s contribution to cardiovascular risk, along with the latest research on lowering its levels. You’ll also learn how to accurately diagnose Lp(a) and explore effective treatment options, empowering you to better manage this emerging risk factor in your patients’ cardiovascular care.

Learning Objectives

  1. Define LP(a)s role in CVD risk
  2. Examine current research in lowering LP(a)
  3. Explore diagnostic testing to confirm LP(a) diagnosis
  4. Discuss treatment options for patients with LP(a) diagnosis

 

CE certificate available upon successful completion of the post-test and program evaluation.

Non-Member Price

$0

Member Price

$0

CE Contact Hours

0.75

Pharmacology CE Hours

0.25

Keith Ferdinand

MD, FACC, FAHA, FASH, FASPC, FNLA

AANP-provider-logo

Accreditation:

PCNA is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030602.